The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

sequentiabiotech.com

Founded Year

2013

Stage

Grant | Alive

About Sequentia Biotech

Sequentia Biotech is a bioinformatics company that transforms omics data into knowledge. The company offers bioinformatics cloud softwares, custom softwares and bioinformatics consulting services for healthcare, pharma, agriculture, industry and the environment.

Sequentia Biotech Headquarter Location

Carrer de València, 359, 2º, 1ª

Barcelona, 08009,

Spain

+34 93 010 73 68

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Sequentia Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sequentia Biotech is included in 1 Expert Collection, including Digital Health.

D

Digital Health

13,068 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Sequentia Biotech Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sequentia Biotech Rank

  • When was Sequentia Biotech founded?

    Sequentia Biotech was founded in 2013.

  • Where is Sequentia Biotech's headquarters?

    Sequentia Biotech's headquarters is located at Carrer de València, 359, 2º, 1ª, Barcelona.

  • What is Sequentia Biotech's latest funding round?

    Sequentia Biotech's latest funding round is Grant.

  • Who are the investors of Sequentia Biotech?

    Investors of Sequentia Biotech include Executive Agency for Small and Medium-sized Enterprises.

  • Who are Sequentia Biotech's competitors?

    Competitors of Sequentia Biotech include CJ Bioscience and 4 more.

You May Also Like

Karius Logo
Karius

Karius is a life sciences company focused on conquering infectious diseases through the use of sequencing to analyze microbial cell-free DNA. The company's genomics platform delivers insight into the microbial landscape, providing clinicians with a comprehensive test capable of identifying more than a thousand pathogens directly from blood and helping industry accelerate drug development.

A
ACGT

ACGT develops genomics-based solutions that increase productivity and enhance value creation from the oil palm and other oil crops. It is based in Kuala Lumpur, Malaysia.

Omixon Logo
Omixon

Omixon is a global molecular diagnostics company that commercializes technologies for clinical and research laboratories. Omixon's flagship product, Holotype HLA, is an NGS-based HLA genotyping product that delivers high-resolution HLA genotyping. Omixon's research software, HLA Explore, analyzes data from any sequencing technology and determines HLA genotypes from whole exome/genome sequencing experiments.

Aperiomics Logo
Aperiomics

Aperiomics identifies bacteria, viruses, fungi, and parasites through Deep Shotgun Metagenomic Sequencing, using its database of microbes. The company helps doctors and their patients identify the causes of infections that other tests cannot identify, thus streamlining the path to a positive clinical outcome.

S
Stratos Genomics

Stratos Genomics is a biotechnology company that develops genome sequencing through the Sequencing by Expansion (SBX) method, a single-molecule detection process that circumvents the limitations of competing technologies.On June 1st, 2020 Stratos Genomics was acquired by Roche. The terms of the transaction were not disclosed.

CJ Bioscience Logo
CJ Bioscience

CJ Bioscience (KOSDAQ: 311690) is a bioinformatics company that develops data-driven microbiome therapeutics solutions for the microbiology sector. The company's suite of tools includes EzBioCloud, a database for academic research and commercial development, and BIOiPLUG, a cloud-based bioinformatics and analysis platform. It was founded in 2009 and is based in Seoul, South Korea.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.